4//SEC Filing
MOULDER LEON O JR 4
Accession 0001104659-24-101773
CIK 0001953926other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 6:34 PM ET
Size
12.7 KB
Accession
0001104659-24-101773
Insider Transaction Report
Form 4
MOULDER LEON O JR
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-09-19$17.89/sh+5,000$89,450→ 1,667,039 total(indirect: See Footnote) - Purchase
Common Stock
2024-09-20$17.88/sh+2,367$42,322→ 1,669,406 total(indirect: See Footnote) - Purchase
Common Stock
2024-09-18$17.91/sh+10,000$179,100→ 1,662,039 total(indirect: See Footnote) - Purchase
Common Stock
2024-09-20$18.97/sh+2,633$49,948→ 1,672,039 total(indirect: See Footnote)
Holdings
- 161,155
Common Stock
Footnotes (5)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.50 to $18.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.64 to $18.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.70 to $18.27, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $18.35 to $19.24, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001228865
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 6:34 PM ET
- Size
- 12.7 KB